Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Montedoro

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Recenti Progressi in Medicina|June 16, 2026
Antonio Tornincasa, Michele Montedoro
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|June 23, 2004
[Taxanes as adjuvants in breast cancer. What repercussions will this have in clinical practice?]Anna Maria Mosconi, Michele Montedoro
Current Oncology (Toronto, Ont.)|April 25, 2025
New Therapeutic Scenarios in the Context of Adjuvant Treatment for HR+/HER2-Breast Cancer: The Possible Role of Ribociclib in Treatment Algorithms for Stage II and IIINicola Battelli, Carmela Mocerino, Michele Montedoro, et al.
Anticancer Research|May 31, 2024
Neoadjuvant Treatment for a cT4cN+ HER2+ Breast Cancer: Case Report of a Therapeutic SuccessMarco Gunnellini, Antonio Tornincasa, Michele Montedoro, et al.
BMC Infectious Diseases|June 8, 2024
The Hospital Burden of Flu in Italy: a retrospective study on administrative data from season 2014-2015 to 2018-2019Riccardo Cipelli, Serena Falato, Eleonora Lusito, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Recenti Progressi in Medicina|June 16, 2026
Antonio Tornincasa, Michele Montedoro
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|June 23, 2004
[Taxanes as adjuvants in breast cancer. What repercussions will this have in clinical practice?]Anna Maria Mosconi, Michele Montedoro
Current Oncology (Toronto, Ont.)|April 25, 2025
New Therapeutic Scenarios in the Context of Adjuvant Treatment for HR+/HER2-Breast Cancer: The Possible Role of Ribociclib in Treatment Algorithms for Stage II and IIINicola Battelli, Carmela Mocerino, Michele Montedoro, et al.
Anticancer Research|May 31, 2024
Neoadjuvant Treatment for a cT4cN+ HER2+ Breast Cancer: Case Report of a Therapeutic SuccessMarco Gunnellini, Antonio Tornincasa, Michele Montedoro, et al.
BMC Infectious Diseases|June 8, 2024
The Hospital Burden of Flu in Italy: a retrospective study on administrative data from season 2014-2015 to 2018-2019Riccardo Cipelli, Serena Falato, Eleonora Lusito, et al.
Pageof 1